BioLumina provides a premium topical aesthetic serum formulated with Day Zero Exosomes derived from amniotic fluid and Wharton's Jelly. This unadulterated suspension contains exosomes, growth factors, microRNA, and peptides designed to support dermal scaffolding renewal. The product aims to reduce visible signs of aging, improve skin tone, and enhance elasticity through regenerative biological agents.
Funding
Funding not disclosed
Founders
Product
Problem
As people age, their skin loses elasticity and collagen, leading to visible signs of aging such as fine lines, wrinkles, hyperpigmentation, and thinning hair. Traditional methods to combat these signs can be invasive and may not fully restore the skin's youthful appearance.
Solution
BioLumina™: Day Zero Exosomes™ is a topical aesthetic treatment designed to rejuvenate skin and reduce the signs of aging. The product utilizes a blend of exosomes, peptides, micro RNA, and growth factors suspended in pure amniotic fluid and Wharton's Jelly. This combination aims to stimulate collagen production, improve skin tone and elasticity, and diminish the appearance of fine lines, wrinkles, and sun damage. The formulation preserves the signaling pathways between regenerative agents, creating an environment conducive to tissue growth and development.
Target Audience
The primary target audience includes individuals seeking non-invasive aesthetic treatments to reduce the visible signs of aging and improve overall skin appearance.
Features
- Contains a blend of exosomes, peptides, micro RNA, and growth factors.
- Suspended in pure amniotic fluid and Wharton's Jelly.
- Aims to boost collagen production.
- May reduce the appearance of fine lines and wrinkles.
- May improve skin tone and elasticity.
- May improve discolorations of the skin.
- 100% natural and full strength, without dilutants.
- Contains Hyaluronan for hydration and lubrication.
- Includes Collagen Types I, II, & V.